
Keywords: Skin; TGFβ; Inflammation; Extracellular matrix; Therapy; ACE; angiotensin-converting enzyme; ACE2; angiotensin-converting enzyme 2; AT1; angiotensin II receptor type 1; ADAM; a disintegrin and metalloproteinase family sheddase; AT2; angiotensin II recept